Tata Memorial Hospital: Admission Process Simplified

how to admit in tata memorial hospital

The Tata Memorial Hospital, located in Parel, Mumbai, is India's oldest and largest cancer institute. It was initially commissioned by the Sir Dorabji Tata Trust in 1941 and is now a part of the Tata Memorial Centre (TMC), an autonomous grant-aid institution under the Department of Atomic Energy, Government of India. TMC focuses on evidence-based cancer management and offers patients the option to choose between 'general' and 'private' payment categories, with extremely poor patients treated at a nominal cost. The hospital is also a teaching centre affiliated with the Homi Bhabha National University, with around 80 post-graduate students registering annually for Master's or Doctorate courses. Admissions for these courses are made through NEET, with 50% All India Quota and 50% State Quota.

Tata Memorial Hospital Admission

Characteristics Values
Founding Body Sir Dorabji Tata Trust
Year of Commission 28 February 1941
Purpose Advancement of learning and research, disaster relief, and other philanthropic activities
Current Affiliation Department of Atomic Energy, Government of India
Recognition WHO, IAEA, UICC
Courses Offered Master's and Doctorate courses
Number of Annual Registrations 80 post-graduate students
Admission Criteria NEET (50% All India Quota and 50% State Quota)
Payment Categories General, Private, Nominal Cost (for the extremely poor)

shunhospital

Tata Memorial Centre (TMC) is an autonomous institution under the Department of Atomic Energy, Government of India

The Tata Memorial Centre (TMC) is a leader in cancer education, research, and treatment in India. It is an autonomous grant-in-aid institution under the Department of Atomic Energy, Government of India. The TMC umbrella includes over 10 cancer institutes across India, with the Tata Memorial Hospital (TMH) in Parel, Mumbai, serving as the largest and central hub. TMH is India's oldest and largest cancer institute, established in 1941 by the Sir Dorabji Tata Trust to advance learning, research, and philanthropic activities following the death of Dorabji's wife, Meherbai, from leukaemia.

TMH has been at the forefront of cancer research and treatment in India, achieving numerous milestones. These include India's first linear accelerator for radiation therapy in 1978, the first bone marrow transplant in 1983, the establishment of a tissue bank in 1988, the introduction of PET/CT in 2004, and the recent addition of the first proton therapy unit in a government setup in 2023. The hospital prioritises Evidence-based Medicine (EBM) and Multidisciplinary Team (MDT) management through disease-specific groups to ensure quality patient care.

The TMC is recognised by national and international organisations such as WHO, IAEA, and UICC for its contributions to cancer education and research. It is also a post-graduate teaching centre affiliated with the Homi Bhabha National University, with approximately 80 post-graduate students registering annually for Master's or Doctorate courses. The TMC offers different payment categories, including 'general' and 'private', with the same set of doctors and infrastructure for both. Extremely poor patients are treated at a nominal cost under the 'NC' category, demonstrating TMC's commitment to accessibility and affordability.

Admissions to the TMC for MD courses are made through NEET, with 50% All India Quota and 50% State Quota. For DM and M.Ch. courses, admissions are through the NEET Online National Counselling Round. TMC's dedication to service, education, and research in cancer has solidified its reputation as a premier institution in India's healthcare landscape.

shunhospital

Tata Memorial Hospital (TMH) is India's oldest and largest cancer institute, with a focus on multidisciplinary team (MDT) management

Tata Memorial Hospital (TMH) is India's oldest and largest cancer institute. It was initially commissioned by the Sir Dorabji Tata Trust on 28 February 1941, after Dorabji's wife, Meherbai, passed away from leukaemia. The institute was created to advance learning and research, disaster relief, and other philanthropic activities without any distinction of place, nationality, or creed. In 1952, the Indian Cancer Research Centre was established as a research institute for basic cancer research and was later renamed the Cancer Research Institute (CRI). The Ministry of Health took over the Tata Memorial Hospital in 1957, and in 1962, administrative control of both TMH and CRI was transferred to the Department of Atomic Energy (DAE). These two arms merged to form the Tata Memorial Centre (TMC) in 1966, with a mandate for cancer service, education, and research.

TMH, under the TMC umbrella, has spearheaded India's Evidence-based Medicine (EBM) movement in oncology and prioritises Multidisciplinary Team (MDT) management. This is achieved through disease-specific groups, ensuring quality patient care. TMH was responsible for many firsts in India, including the country's first linear accelerator for radiation therapy in 1978, bone marrow transplant in 1983, tissue bank in 1988, PET/CT in 2004, and the first proton therapy unit in a government setup in 2023. Additionally, TMH has played a pivotal role in the CAR-T cell trial, leading to the approval of indigenous CAR-T cell therapy in the country.

The Tata Memorial Centre's focus on multidisciplinary team management is evident in its dedicated disease management groups for various cancers. Every new patient is discussed by a tumour board consisting of surgical, medical, and radiation oncologists, radiologists, and pathologists. TMC also offers a unique payment structure, providing patients the option to choose between 'general' and 'private' categories, with the same set of doctors and infrastructure for both. This cross-subsidisation model has been successful, with over a million patient footfalls and approximately 60,000 admissions annually from diverse regions.

The Tata Memorial Centre is recognised as a training centre for cancer education and research by prestigious organisations such as the WHO, IAEA, and UICC. It is also a part of the National Cancer Grid (NCG), a network of major cancer centres, research institutes, patient groups, and charitable institutions across India. The NCG aims to establish uniform standards of patient care, provide specialised training, and facilitate collaborative research in cancer. With its rich history, pioneering achievements, and dedication to multidisciplinary patient care, Tata Memorial Hospital remains at the forefront of cancer treatment and research in India.

shunhospital

TMH offers different payment classes for patients, including a nominal cost option for those who are extremely poor

Tata Memorial Hospital (TMH) is India's oldest and largest cancer institute, located in Parel, Mumbai. It is a post-graduate teaching centre affiliated with the Homi Bhabha National University. TMH offers a range of courses, including MD, M.Sc, DM, M.Ch, Advanced Diploma, and Certified HBNI Fellowship programmes. It also prioritises multidisciplinary team (MDT) management through disease-specific groups to ensure quality patient care.

TMH offers different payment classes for patients, allowing them to choose between the 'general' and 'private' categories. This flexibility ensures that patients from diverse economic backgrounds can access the same set of doctors and infrastructure. Notably, TMH also has a special consideration for extremely poor patients, offering treatment at a nominal cost under the 'NC' (Nominal Cost) category. This cross-subsidization model has been impactful, with over a million patient footfalls and approximately 60,000 admissions annually from various regions.

The Tata Memorial Centre (TMC), of which TMH is the central hub, includes at least ten cancer institutes across India. TMC is an autonomous grant-in-aid institution administered by the Department of Atomic Energy, under the Government of India. It is recognised by organisations such as WHO, IAEA, and UICC for its contributions to cancer education and research.

TMH accepts various payment methods, including credit cards, debit cards, net banking, and cash or cheques, making it convenient for patients to settle their medical expenses using their preferred payment option.

The fees for the programmes offered by TMH vary. For instance, the tuition fee for the DM in Medical Oncology programme is INR 3.45 Lakhs. Students interested in pursuing postgraduate studies at TMH can refer to the institution's website or other official sources for detailed information on admission procedures, fees, and available specialisations.

shunhospital

Admissions for MD courses are made through NEET with a 50% All India Quota and 50% State Quota

To be admitted to the Tata Memorial Hospital for an MD course, candidates must qualify for the NEET-PG (National Eligibility cum Entrance Test for Postgraduate). NEET is a national-level test that is the primary gateway to various medical programs in both government and private medical colleges. Admissions for MD courses are made through NEET with a 50% All India Quota and 50% State Quota.

The NEET-PG score is mandatory for both government and private college admissions. Candidates with an MBBS qualification from a recognised medical college can apply for MD courses. After qualifying for NEET-PG, candidates must participate in the counselling process, which includes All India Quota counselling, State Quota counselling, and Deemed University counselling.

For All India Quota counselling, 50% of the seats are reserved for candidates from across India. Candidates from Jammu and Kashmir are not eligible for these seats but can apply for the state quota. The remaining 50% of seats are for state-domicile students, with each state filling 85% of its government medical college seats based on reservation policies and domicile criteria. The inter se merit of candidates with equal marks in NEET-UG is determined by higher marks in Biology and Chemistry and, subsequently, by the candidate's age.

State counselling authorities create separate state merit lists for the 85% quota based on domicile, reservation categories, and other local eligibility criteria. Candidates must register to seek seats under the State Quota and contact the corresponding state admission officials and the Directorate of Medical Education. It is important to note that candidates can apply for both State Quota and All India Quota simultaneously, but once they confirm admission under one quota, they typically must forfeit the other.

shunhospital

Tata Memorial Centre is a recognised training centre for cancer education and research, affiliated with the Homi Bhabha National University

The Tata Memorial Centre (TMC) is a comprehensive cancer centre for the prevention, treatment, and research of cancer. It is a recognised training centre for cancer education and research, affiliated with the Homi Bhabha National Institute. With a mission centred on providing compassionate cancer care for all, approximately 60% of patients receive free or subsidised treatments. The centre lays a lot of emphasis on cancer education, with over 250 students, medical professionals, scientists, and technicians undergoing training at the hospital.

TMC offers residency programmes in general surgery, radiotherapy, pathology, and anaesthesiology, along with super-speciality and research programmes. It has collaborations with various cancer centres across India and international organisations such as the World Health Organization, the National Institute of Health, Washington DC, and the Bill and Melinda Gates Foundation.

The centre is equipped with advanced facilities, including robotic surgery, proton therapy, 24-hour chemotherapy units, modern diagnostic tools, and bone marrow transplants. TMC prioritises Multidisciplinary Team (MDT) management through disease-specific groups to ensure quality patient care. It has been at the forefront of cancer research and treatment in India, with several notables firsts, including the country's first linear accelerator for radiation therapy and the approval of indigenous CAR-T cell therapy.

The Tata Memorial Hospital, the central hub of TMC, was initially commissioned by the Sir Dorabji Tata Trust in 1941 after Dorabji's wife, Meherbai, passed away from leukaemia. This tragic event spurred him to establish a centre dedicated to researching and combating the disease. In 1952, the Indian Cancer Research Centre was established, later renamed the Cancer Research Institute (CRI). In 1966, TMH merged with the Indian Cancer Research Institute and was renamed the Tata Memorial Centre.

Frequently asked questions

The Tata Memorial Hospital is India's oldest and largest cancer institute, with a focus on cancer education, research, and treatment. It was initially commissioned by the Sir Dorabji Tata Trust in 1941 to advance learning, research, and philanthropic activities.

For MD courses, admissions are made through NEET with a 50% All India Quota and a 50% State Quota. For DM/M.Ch. courses, admissions are made through NEET's Online National Counselling Round.

Patients can choose between 'general' and 'private' payment categories, with the same set of doctors and infrastructure for both. Extremely poor patients can be treated at a nominal cost.

Tata Memorial Hospital is at the forefront of cancer research and treatment in India. It was the first to introduce a linear accelerator for radiation therapy, bone marrow transplants, a tissue bank, PET/CT, and the second proton therapy unit in the country. The hospital also prioritizes multidisciplinary team management to ensure quality patient care.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment